New Covid Variant PJ.2.1 Spreads Across North America, Europe, Australia, and Asia

A new COVID-19 variant, PJ.2.1, first detected in Canada in May 2026, is spreading across North America, Europe, Australia, and Asia, raising concerns about a potential new wave of infections. Research published in the Journal of Infection suggests PJ.2.1's spread may be linked to increased binding to the ACE2 receptor rather than significant immune evasion. Laboratory tests show vaccine-induced antibodies can still neutralize the variant, though real-world effectiveness remains unestablished. The WHO has not designated PJ.2.1 as a variant of concern, and there is insufficient evidence it causes more severe illness than previous variants. Symptoms overlap with flu and colds, making diagnostic testing important for accurate identification.